Phase 3, open-label trial of lenalidomide and low-dose dexamethasone with or without pembrolizumab (MK-3475) in newly diagnosed, treatment-naïve multiple myeloma who are ineligible for autologous stem cell transplant - Regional Cancer Care Associates LLC

Clinical Trials

Phase 3, open-label trial of lenalidomide and low-dose dexamethasone with or without pembrolizumab (MK-3475) in newly diagnosed, treatment-naïve multiple myeloma who are ineligible for autologous stem cell transplant

Type of Cancer
Multiple Myeloma
Locations
East Brunswick
Freehold
Howell
Little Silver
Mount Holly
Sparta
Sponsor
Merck
Protocol Number
3475-185
Cancer Diagnosis
To Learn More Call
201-510-0910